Position in ATYR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$391,662
-$888,509 QoQ
Shares Held
656,051
-60.0% QoQ
Ownership
0.669%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 90 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATYR Over Time
Shares Held
Position Value (USD)
Derivatives in ATYR
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$253,500
PutShares
50,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,585,112 across 322 Biotechnology names. ATYR ranks #275 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in ATYR
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $391,662 | 656,051 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,280,171 | 1,641,246 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $1,363,354 | 1,890,921 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $253,500 | 50,000 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $8,113,014 | 1,600,200 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,829,103 | 1,599,041 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,332,120 | 367,989 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $191,234 | 108,656 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $166,033 | 106,432 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $121,837 | 62,481 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $176,568 | 125,226 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $133,216 | 84,314 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $760,544 | 352,104 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $149,152 | 68,106 | Shares | Sole | 2023-02-14 | |
| 2021-12-31 | $146,830 | 19,656 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $217,629 | 23,968 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $148,283 | 30,386 | Shares | Sole | 2021-08-16 | |
| 2020-09-30 | $73,550 | 22,771 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $62,395 | 22,284 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||